Last edition
News about "mogamulizumab"
Knight Therapeutics Signs Latin America Deal for Mogamulizumab
Knight Therapeutics will seek regulatory approval and commercialise mogamulizumab in Brazil, Mexico, Colombia and Argentina under its agreement with Kyowa Kirin International.
Mogamulizumab | 30/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members